Envestnet Asset Management Inc Alkermes Plc. Transaction History

Envestnet Asset Management Inc

$299 Billion
Q1 2025

A detailed history of Envestnet Asset Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 43,107 shares of ALKS stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,107

Previous 47,594 9.43%

Holding current value

$1.23 Million

Previous $1.37 Million 4.02%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$28.08 - $36.0 $125,994 - $161,532	-4,487 Reduced 9.43%	43,107 $1.42 Million
Q4 2024 Feb 12, 2025	BUY	$25.7 - $31.46 $81,700 - $100,011	3,179 Added 7.16%	47,594 $1.37 Million
Q3 2024 Nov 06, 2024	SELL	$23.01 - $28.55 $84,009 - $104,236	-3,651 Reduced 7.6%	44,415 $1.24 Million
Q2 2024 Aug 08, 2024	SELL	$23.21 - $27.24 $48,439 - $56,849	-2,087 Reduced 4.16%	48,066 $1.16 Million
Q1 2024 May 13, 2024	BUY	$26.4 - $32.56 $75,451 - $93,056	2,858 Added 6.04%	50,153 $1.36 Million
Q4 2023 Feb 13, 2024	BUY	$23.37 - $28.68 $445,689 - $546,956	19,071 Added 67.57%	47,295 $1.31 Million
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $225,918 - $265,830	8,315 Added 41.77%	28,224 $790,000
Q2 2023 Aug 04, 2023	SELL	$28.34 - $33.63 $691,496 - $820,572	-24,400 Reduced 55.07%	19,909 $623,000
Q1 2023 May 11, 2023	BUY	$25.31 - $29.02 $1.12 Million - $1.29 Million	44,309 New	44,309 $1.25 Million
Q2 2022 Aug 03, 2022	BUY	$26.4 - $30.54 $110,827 - $128,206	4,198 Added 23.63%	21,967 $654,000
Q1 2022 May 04, 2022	BUY	$23.07 - $27.99 $77,607 - $94,158	3,364 Added 23.35%	17,769 $468,000
Q4 2021 Feb 04, 2022	BUY	$21.47 - $32.08 $309,275 - $462,112	14,405 New	14,405 $335,000
Q3 2018 Nov 14, 2018	SELL	$38.6 - $46.12 $275,179 - $328,789	-7,129 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$40.56 - $51.36 $321,681 - $407,336	-7,931 Reduced 52.66%	7,129 $293,000
Q1 2018 May 09, 2018	SELL	$53.61 - $67.26 $264,511 - $331,860	-4,934 Reduced 24.68%	15,060 $872,000
Q4 2017 Feb 20, 2018	SELL	$47.69 - $55.39 $187,755 - $218,070	-3,937 Reduced 16.45%	19,994 $1.09 Million
Q3 2017 Nov 13, 2017	SELL	$49.16 - $54.45 $1,966 - $2,178	-40 Reduced 0.17%	23,931 $1.22 Million
Q2 2017 Aug 14, 2017	BUY	N/A	23,971	23,971 $1.39 Million

Others Institutions Holding ALKS

# of Institutions

410

Shares Held

177M

Call Options Held

229K

Put Options Held

436K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.7B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Alkermes Plc. Transaction History